DE69021000T2 - Radiomarkierte Peptide mit Antikoagulanswirkung. - Google Patents

Radiomarkierte Peptide mit Antikoagulanswirkung.

Info

Publication number
DE69021000T2
DE69021000T2 DE69021000T DE69021000T DE69021000T2 DE 69021000 T2 DE69021000 T2 DE 69021000T2 DE 69021000 T DE69021000 T DE 69021000T DE 69021000 T DE69021000 T DE 69021000T DE 69021000 T2 DE69021000 T2 DE 69021000T2
Authority
DE
Germany
Prior art keywords
anticoagulant activity
radiolabeled peptides
radiolabeled
peptides
anticoagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69021000T
Other languages
English (en)
Other versions
DE69021000D1 (de
Inventor
John L Krstenansky
Simon J T Mao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69021000D1 publication Critical patent/DE69021000D1/de
Application granted granted Critical
Publication of DE69021000T2 publication Critical patent/DE69021000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/815—Protease inhibitors from leeches, e.g. hirudin, eglin
DE69021000T 1989-10-03 1990-10-03 Radiomarkierte Peptide mit Antikoagulanswirkung. Expired - Fee Related DE69021000T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41633589A 1989-10-03 1989-10-03

Publications (2)

Publication Number Publication Date
DE69021000D1 DE69021000D1 (de) 1995-08-24
DE69021000T2 true DE69021000T2 (de) 1996-04-04

Family

ID=23649537

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69021000T Expired - Fee Related DE69021000T2 (de) 1989-10-03 1990-10-03 Radiomarkierte Peptide mit Antikoagulanswirkung.

Country Status (18)

Country Link
US (1) US5279812A (de)
EP (1) EP0421366B1 (de)
JP (1) JP2899390B2 (de)
KR (1) KR0168644B1 (de)
CN (1) CN1050721A (de)
AT (1) ATE125269T1 (de)
AU (1) AU631681B2 (de)
CA (1) CA2026377A1 (de)
DE (1) DE69021000T2 (de)
ES (1) ES2076999T3 (de)
FI (1) FI904851A0 (de)
HU (1) HU207525B (de)
IE (1) IE903531A1 (de)
IL (1) IL95864A0 (de)
NO (1) NO904291L (de)
NZ (1) NZ235499A (de)
PT (1) PT95485A (de)
ZA (1) ZA907743B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395609A (en) * 1989-06-19 1995-03-07 Antisoma Limited Synthetic peptides for use in tumor detection
GB8914020D0 (en) * 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
DK0540574T3 (da) * 1990-07-24 1996-09-30 Merrell Pharma Inc Antikoagulationspeptider
ZA915658B (en) * 1990-07-24 1992-05-27 Merrell Dow Pharma Analogs of hirudin having antiplatelet activity
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
WO1993004082A1 (en) * 1991-08-20 1993-03-04 Baxter International Inc. Analogs of hirudin
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
DE69330494T2 (de) * 1992-02-05 2002-03-28 Mallinckrodt Inc Radioaktiv markierte somatostatin
US5750088A (en) 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
PT702696E (pt) * 1993-06-11 2003-12-31 Merrell Pharma Inc Peptidos trifuncionais antitrombina e antiplaquetas
US5457177A (en) * 1993-06-16 1995-10-10 Merck & Co., Inc. Thrombin receptor radioligands
WO1995032173A1 (fr) * 1994-05-24 1995-11-30 Eisai Co., Ltd. Compose porteur de deux groupes 2,6-diiodophenol-4-yl et medicament de diagnostic de l'allergie a l'iode
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
US6685914B1 (en) * 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
DE60333830D1 (de) * 2002-04-30 2010-09-30 Univ Emory Verbindungen zur abbildung von tumoren
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
CN100402092C (zh) * 2005-06-07 2008-07-16 西安交通大学 血栓诊断和/或治疗用含气干粉活性剂及其制备工艺
EP1893244A4 (de) * 2005-06-23 2009-06-24 Univ Emory Kontrastmittel
EP1893246A4 (de) * 2005-06-23 2009-05-06 Univ Emory Stereoselektive synthese von aminosäureanaloga für tumorbildgebung
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
CN110437307B (zh) * 2019-07-26 2020-11-13 暨南大学 一类具抗血栓和脑神经细胞保护作用的水蛭多肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5850213B2 (ja) * 1977-06-20 1983-11-09 株式会社第一ラジオアイソト−プ研究所 カルチトニンの定量法
DE3040824A1 (de) * 1980-10-30 1982-08-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neues dekapeptid, verfahren zu seiner herstellung und verwendung
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4585740A (en) * 1983-05-03 1986-04-29 The Whittier Institute For Diabetes And Endocrinology Prolactin immunoassay using synthetic peptide
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
CA1328540C (en) * 1987-05-21 1994-04-12 John L. Krstenansky Cyclic anticoagulant peptides
CA1340646C (en) * 1987-05-21 1999-07-13 John L. Krstenansky Cyclic anticoagulant peptides
AU3098289A (en) * 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides

Also Published As

Publication number Publication date
ZA907743B (en) 1991-07-31
DE69021000D1 (de) 1995-08-24
AU6368990A (en) 1991-04-11
HUT55801A (en) 1991-06-28
NO904291L (no) 1991-04-04
FI904851A0 (fi) 1990-10-02
IL95864A0 (en) 1991-07-18
EP0421366B1 (de) 1995-07-19
PT95485A (pt) 1991-06-25
AU631681B2 (en) 1992-12-03
CN1050721A (zh) 1991-04-17
HU906271D0 (en) 1991-03-28
EP0421366A1 (de) 1991-04-10
ES2076999T3 (es) 1995-11-16
CA2026377A1 (en) 1991-04-04
JP2899390B2 (ja) 1999-06-02
KR0168644B1 (ko) 1999-01-15
NO904291D0 (no) 1990-10-02
US5279812A (en) 1994-01-18
JPH03120296A (ja) 1991-05-22
HU207525B (en) 1993-04-28
KR910007959A (ko) 1991-05-30
ATE125269T1 (de) 1995-08-15
NZ235499A (en) 1993-04-28
IE903531A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
DE69021000T2 (de) Radiomarkierte Peptide mit Antikoagulanswirkung.
DE68917637D1 (de) Mit Luft angetriebene Tragevorrichtung für einen Körper.
DE69032258D1 (de) Antikoagulierende Peptide
ES2060689T3 (es) Alcoholes peptidicos anticoagulantes.
IT1215973B (it) Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
ES2131041T3 (es) Peptidos anticoagulantes.
DE69122103T2 (de) Antigerinnungspeptide
ATE139121T1 (de) Hirudin-analoge mit antiblutplättchen-aktivität
FR2603464B1 (fr) Chaussure anti-fatigue

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee